Sumitomo Pharma Co., Ltd. Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd.

4506

Classement en actions #3225
Sumitomo Pharma Co., Ltd. is a global company involved in the creation,... Sumitomo Pharma Co., Ltd. is a global company involved in the creation, production, and sale of a variety of products, including human pharmaceuticals, food ingredients and additives, and veterinary medicines. Its operations span across Japan, North America, China, and other international territories. The company's pharmaceutical offerings address a broad spectrum of medical needs. These include treatments for conditions such as Parkinson's disease, depression, type 2 diabetes, systemic fungal infections, hypertension, pruritus, chronic obstructive pulmonary disease (COPD), angina pectoris, and arrhythmia. Additionally, they manufacture atypical antipsychotics, antiepileptics, carbapenem antibiotics, gastrointestinal products, and specialized medications for Anderson-Fabry disease. Beyond healthcare, Sumitomo Pharma provides food components and enhancement agents like polysaccharides, along with savory flavorings such as soups and bouillons. The company also supplies chemical raw materials, which encompass pharmaceutical excipients, components for personal care products, substances used in coatings and industrial applications, and electronic materials. Moreover, it produces veterinary therapeutic solutions designed for domestic pets, specifically dogs and cats, as well as for various farm animals, including cattle, swine, poultry, horses, and cultivated fish. To drive innovation, Sumitomo Pharma fosters partnerships with several organizations. These collaborators include Healios K.K., Keio University, RIKEN, the Center for iPS Cell Research and Application, Kyoto University, and Aikomi Co., Ltd. The company also maintains a joint development agreement with SanBio Company Limited, a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd., and a strategic alliance with Roivant Sciences Ltd. Originally established in 1897, the company, headquartered in Osaka, Japan, was known as Sumitomo Dainippon Pharma Co., Ltd. until it adopted its current name, Sumitomo Pharma Co., Ltd., in April 2022. It functions as a subsidiary of Sumitomo Chemical Company, Limited.
Prix de l'action
$12.28
Capitalisation boursière
$5.51B
Changement (1 jour)
0.59%
Changement (1 an)
8.21%
Pays
JP
Échange Sumitomo Pharma Co., Ltd. (4506)

Catégorie

Healthcare
Historique des dividendes pour Sumitomo Pharma Co., Ltd. (4506)
Sumitomo Pharma Co., Ltd. (symbole boursier : 4506) a versé un total de 47 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : $382.25
Rendement du dividende (TTM) : 0
Versements de dividendes pour Sumitomo Pharma Co., Ltd. (4506) de 2000 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
2026 (TTM) $7.00 0.00%
2023 $7.00 -75.00%
2022 $28.00 0.00%
2021 $28.00 0.00%
2020 $28.00 75.00%
2019 $16.00 -15.79%
2018 $19.00 72.73%
2017 $11.00 -38.89%
2016 $18.00 0.00%
2015 $18.00 0.00%
2014 $18.00 0.00%
2013 $18.00 0.00%
2012 $18.00 0.00%
2011 $18.00 0.00%
2010 $18.00 0.00%
2009 $18.00 0.00%
2008 $18.00 12.50%
2007 $16.00 77.78%
2006 $9.00 -10.00%
2005 $10.00 0.00%
2004 $10.00 0.00%
2003 $10.00 -6.98%
2002 $10.75 26.47%
2001 $8.50 -5.56%
2000 $9.00 0.00%
Liste de tous les paiements de dividendes
Année Dividende Changez
2026 (TTM) $7.00 0.00%
2023 $7.00 -75.00%
2022 $28.00 0.00%
2021 $28.00 0.00%
2020 $28.00 75.00%
2019 $16.00 -15.79%
2018 $19.00 72.73%
2017 $11.00 -38.89%
2016 $18.00 0.00%
2015 $18.00 0.00%
2014 $18.00 0.00%
2013 $18.00 0.00%
2012 $18.00 0.00%
2011 $18.00 0.00%
2010 $18.00 0.00%
2009 $18.00 0.00%
2008 $18.00 12.50%
2007 $16.00 77.78%
2006 $9.00 -10.00%
2005 $10.00 0.00%
2004 $10.00 0.00%
2003 $10.00 -6.98%
2002 $10.75 26.47%
2001 $8.50 -5.56%
2000 $9.00 0.00%
Dividendes versés par des entreprises similaires ou concurrentes